BioBehavioral Diagnostics closes $7 million tranche in Series B round

February 1, 2010 by MassDevice staff

BioBehavioral Diagnostics Co. pulls in $7 million in a Series B round it hopes will reach $10 million.

BioBehavioral Diagnostics logo

BioBehavioral Diagnostics Co., which is developing a system to diagnose attention-deficit hyperactivity disorder, closed a $7 million tranche in a Series B round it hopes will reach $10 million.

The Westford, Mass.-based company said it will use the money to expand its sales and marketing operation and fund additional clinical work for its Quotient system.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp